World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 11 April 2016
Main ID:  NCT02409602
Date of registration: 01/04/2015
Prospective Registration: No
Primary sponsor: Near East University, Turkey
Public title: Influence of BIIAL Following PPH on Dorsal Clitoral Artery Blood Flow and FSFI
Scientific title: Comparison of the Dorsal Clitoral Artery Doppler Examination Results and the Female Sexual Function Index in Women With Postpartum Hemorrhage Who Underwent Bilateral Internal Iliac Artery Ligation and Age-matched Healthy Postpartum Women
Date of first enrolment: October 2014
Target sample size: 20
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02409602
Study type:  Observational
Study design:  Observational Model: Case Control, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Turkey
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- 18-35 year-old women who underwent bilateral internal iliac artery ligation (BIIAL)
due to postpartum hemorrhage

- Age-matched healthy puerperal women

Exclusion Criteria:

- Known Diabetes Melitus or cardiovascular disease

- Known affection disorder before or during pregnancy

- B-lynch procedure, ligation of uterine or ovarian artery, hysterectomy and
salphingooophorectomy following postpartum hemorrhage

- Known functional sexual disorder before pregnancy

- Postoperative endometritis or other puerperal infections

- Postoperative thromboembolic incidence

- Cessation of breastfeeding in puerperal period



Age minimum: 18 Years
Age maximum: 35 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Bilateral Iliac Artery Ligation
Postpartum Hemorrhage
Intervention(s)
Other: Doppler ultrasonographic examination
Primary Outcome(s)
Pulsatile index (PI) [Time Frame: 6 months]
Peak diastolic velocity (PDV) [Time Frame: 6 months]
Peak systolic velocity (PSV) [Time Frame: 6 months]
Resistive index (RI) [Time Frame: 6 months]
Systolic/diastolic (S/D) ratio [Time Frame: 6 months]
End diastolic velocity (EDV) [Time Frame: 6 Months]
Secondary Outcome(s)
Secondary ID(s)
CLITDOP-001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history